文献速递腹部技术与安全PETCT

18F-FDG PET影像组学分析预测胰腺导管腺癌隐匿性肝转移

18F-FDG PET Radiomic Analysis to Predict Occult Liver Metastases of Pancreatic Ductal Adenocarcinoma.
PubMed 文献 · Acad Radiol · 2025-10-31

本研究回顾性纳入117例接受术前18F-FDG PET/CT并手术切除的胰腺导管腺癌患者,构建影像组学机器学习模型预测隐匿性肝转移。逻辑回归影像组学模型在测试队列中AUC达0.936,优于基于黄疸、代谢性肿瘤直径和最大标准化摄取值等常规参数的临床模型(AUC 0.755,P<0.001)。融合影像组学与临床变量的融合模型为术前风险分层提供了综合工具,可能有助于指导个体化治疗策略。

要点

  • 术前18F-FDG PET影像组学逻辑回归模型预测胰腺导管腺癌隐匿性肝转移的测试队列AUC为0.936。
  • 基于黄疸、代谢性肿瘤直径和最大标准化摄取值的临床模型AUC为0.755,影像组学模型优于临床模型(P<0.001)。
  • 融合影像组学与临床特征的融合模型可用于术前风险分层,可能指导个体化治疗规划。

核心结论

  • 在这项探索性研究中,18F-FDG PET影像组学模型对胰腺导管腺癌隐匿性肝转移显示出有前景的预测性能,优于常规临床参数,有潜力作为术前风险分层的有价值工具,并可能有助于个体化治疗规划。

研究设计与样本

  • 回顾性研究,纳入117例接受术前18F-FDG PET/CT并手术切除的胰腺导管腺癌患者,采用全自动胰腺分割策略从PET图像提取影像组学特征,开发并比较三种机器学习模型(逻辑回归、多层感知机、自适应提升)与纳入黄疸、代谢性肿瘤直径和最大标准化摄取值的临床模型,并构建融合影像组学特征与临床变量的融合模型,用受试者工作特征曲线和决策曲线分析评估模型性能。

诊断标准与关键数值

  • 隐匿性肝转移定义为术中或术后6个月内发现的肝转移。
  • 117例患者中15.4%(n=18)存在隐匿性肝转移。
  • 逻辑回归影像组学模型在测试队列中AUC为0.936。
  • 基于常规参数的临床模型AUC为0.755,与影像组学模型比较P<0.001。
  • 亚组分析证实模型在不同黄疸状态、肿瘤位置和碳水化合物抗原19-9水平下具有稳健性。

临床应用与阅片要点

  • 作者认为,融合影像组学与临床特征的融合模型可为术前风险分层提供综合工具,并可能有助于指导个体化治疗策略。
  • 作者指出,18F-FDG PET影像组学模型有潜力作为术前风险分层的有价值工具,并可能有助于个体化治疗规划。

局限性

  • 原文在结论中自述为探索性研究。
  • 原文在结论中表述该模型「显示出有前景的预测性能」「有潜力」,并使用了「可能有助于」等限定语气。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

RATIONALE AND OBJECTIVES: To develop and validate a preoperative predictive model for occult liver metastases (OLM) in pancreatic ductal adenocarcinoma (PDAC) using fluorine-18 fluorodeoxyglucose positron emission tomography (18F-FDG PET) radiomics.

MATERIAL AND METHODS: This retrospective study included 117 patients with PDAC who underwent preoperative 18F-FDG PET/CT and surgical resection. OLM was defined as liver metastases detected during surgery or within 6 months postoperatively. A fully automated pancreas segmentation strategy was employed, and radiomic features were extracted from PET images. Three machine learning models (logistic regression, multilayer perceptron, and adaptive boosting) were developed and compared to a clinical model incorporating jaundice, metabolic tumor diameter, and maximum standardized uptake value. A fusion model integrating PET radiomic features with clinical variables was subsequently constructed. Model performance was evaluated using receiver operating characteristic curves and decision curve analysis.

RESULTS: Among the 117 patients, 15.4% (n=18) had OLM. The logistic regression radiomics model demonstrated favorable predictive performance (area under the curve [AUC]: 0.936 in the testing cohort) compared to a clinical model based on conventional parameters (AUC: 0.755, P<0.001). Subgroup analyses confirmed robustness across different jaundice statuses, tumor locations, and carbohydrate antigen 19-9 levels. The fusion model that integrates radiomic and clinical features provides a comprehensive tool for preoperative risk stratification, with the potential to guide personalized treatment strategies.

CONCLUSION: In this exploratory study, the 18F-FDG PET radiomics model demonstrates promising predictive performance for OLM in PDAC, outperforming conventional clinical parameters. It shows potential as a valuable tool for preoperative risk stratification and may help inform personalized treatment planning.

来源:Acad Radiol,查看原文。版权归原作者所有。

引用

  1. Chen J, Zhang Z, Jin Z, et al. 18F-FDG PET Radiomic Analysis to Predict Occult Liver Metastases of Pancreatic Ductal Adenocarcinoma. Acad Radiol. 2025. PMID: 41176435. doi:10.1016/j.acra.2025.10.024

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。